BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26219870)

  • 1. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
    Quak E; Le Roux PY; Hofman MS; Robin P; Bourhis D; Callahan J; Binns D; Desmonts C; Salaun PY; Hicks RJ; Aide N
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2072-82. PubMed ID: 26219870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
    Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
    Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
    Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does PET SUV Harmonization Affect PERCIST Response Classification?
    Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
    J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.
    Lasnon C; Quak E; Le Roux PY; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
    EJNMMI Phys; 2017 Dec; 4(1):17. PubMed ID: 28560574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging.
    Aklan B; Oehmigen M; Beiderwellen K; Ruhlmann M; Paulus DH; Jakoby BW; Ritt P; Quick HH
    J Nucl Med; 2016 Jan; 57(1):78-84. PubMed ID: 26471697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies.
    Armstrong IS; Kelly MD; Williams HA; Matthews JC
    EJNMMI Phys; 2014 Dec; 1(1):99. PubMed ID: 26501457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
    Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
    J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
    Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
    Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.
    Rogasch JM; Steffen IG; Hofheinz F; Großer OS; Furth C; Mohnike K; Hass P; Walke M; Apostolova I; Amthauer H
    EJNMMI Res; 2015; 5():31. PubMed ID: 25992306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
    Makris NE; Huisman MC; Kinahan PE; Lammertsma AA; Boellaard R
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1507-15. PubMed ID: 23754762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain PET imaging optimization with time of flight and point spread function modelling.
    Prieto E; Martí-Climent JM; Morán V; Sancho L; Barbés B; Arbizu J; Richter JA
    Phys Med; 2015 Dec; 31(8):948-955. PubMed ID: 26249138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.
    Rogasch JM; Hofheinz F; Lougovski A; Furth C; Ruf J; Großer OS; Mohnike K; Hass P; Walke M; Amthauer H; Steffen IG
    EJNMMI Phys; 2014 Dec; 1(1):12. PubMed ID: 26501454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
    Sheikhbahaei S; Marcus C; Wray R; Rahmim A; Lodge MA; Subramaniam RM
    Nucl Med Commun; 2016 Mar; 37(3):288-96. PubMed ID: 26650959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
    Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
    Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of PET image reconstruction using a spatial resolution model.
    Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
    Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.
    Brendle C; Kupferschläger J; Nikolaou K; la Fougère C; Gatidis S; Pfannenberg C
    Eur J Radiol; 2015 Jan; 84(1):158-162. PubMed ID: 25467224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
    Bellevre D; Blanc Fournier C; Switsers O; Dugué AE; Levy C; Allouache D; Desmonts C; Crouet H; Guilloit JM; Grellard JM; Aide N
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1103-12. PubMed ID: 24562642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of both time of flight and point spread function in brain PET image reconstruction.
    Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Apr; 37(4):422-7. PubMed ID: 26637071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.